Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease.
作者信息
Freeman Esther E, McMahon Devon E
机构信息
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
出版信息
J Am Acad Dermatol. 2020 Jun;82(6):e231-e232. doi: 10.1016/j.jaad.2020.04.002. Epub 2020 Apr 9.
Abstract
摘要
相似文献
1
Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease.制定COVID-19皮肤病学指南：将循证医学应用于新发传染病的陷阱。
J Am Acad Dermatol. 2020 Jun;82(6):e231-e232. doi: 10.1016/j.jaad.2020.04.002. Epub 2020 Apr 9.
2
Improving communication about COVID-19 and emerging infectious diseases.改善关于新冠病毒和新发传染病的沟通。
Eur J Clin Invest. 2020 May;50(5):e13225. doi: 10.1111/eci.13225. Epub 2020 May 9.
3
Considerations for dermatology residency applicants underrepresented in medicine amid the COVID-19 pandemic.COVID-19大流行期间医学领域代表性不足的皮肤科住院医师申请人的相关考量因素。
J Am Acad Dermatol. 2020 Sep;83(3):e247-e248. doi: 10.1016/j.jaad.2020.05.141. Epub 2020 Jun 3.
4
The value of early transmission dynamic studies in emerging infectious diseases.新发传染病早期传播动力学研究的价值
Lancet Infect Dis. 2020 May;20(5):512-513. doi: 10.1016/S1473-3099(20)30161-4. Epub 2020 Mar 11.
5
Dermatology and COVID-19.皮肤病学与新型冠状病毒肺炎
JAMA. 2020 Sep 22;324(12):1133-1134. doi: 10.1001/jama.2020.15276.
6
Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.2019冠状病毒病疫情期间的伦理与体外膜肺氧合
Perfusion. 2020 Sep;35(6):562-564. doi: 10.1177/0267659120937545. Epub 2020 Jun 25.
7
[Emerging infections, the great challenge of global health: Covid-19].[新发传染病：全球健康的巨大挑战：新冠疫情]
Salud Publica Mex. 2020 Mar-Apr;62(2):123-124. doi: 10.21149/11284.
8
COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do.新冠疫情：生物多样性下降为何使我们面临更大的新发传染病风险，以及我们能做些什么。
J Gen Intern Med. 2020 Sep;35(9):2746-2747. doi: 10.1007/s11606-020-05977-x. Epub 2020 Jun 25.
9
The immediate impact of COVID-19 on US dermatology practices.2019冠状病毒病对美国皮肤科诊疗业务的直接影响。
J Am Acad Dermatol. 2020 Aug;83(2):685-686. doi: 10.1016/j.jaad.2020.05.048. Epub 2020 May 16.
10
Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic.2019年冠状病毒病（COVID-19）大流行期间的皮肤病学战略临床运营
J Am Acad Dermatol. 2020 Jun;82(6):e207-e209. doi: 10.1016/j.jaad.2020.03.089. Epub 2020 Apr 8.
引用本文的文献
1
Examination of Cutaneous Changes Among Patients Following SARS-CoV-2 Infection.新型冠状病毒感染患者皮肤变化的检查
Cureus. 2022 Jul 20;14(7):e27052. doi: 10.7759/cureus.27052. eCollection 2022 Jul.
2
Cutaneous Manifestations of Coronavirus Disease 2019: Skin Narratives and Dialogues.2019冠状病毒病的皮肤表现：皮肤故事与探讨
J Clin Aesthet Dermatol. 2022 May;15(5):E77-E81.
3
Evidence-Based Medicine in the Field of Ophthalmology during the COVID-19 Pandemic.新冠疫情期间眼科领域的循证医学
J Ophthalmol. 2022 Mar 30;2022:3539134. doi: 10.1155/2022/3539134. eCollection 2022.
4
Analysis of the Evolution of User Emotion and Opinion Leaders' Information Dissemination Behavior in the Knowledge Q&A Community during COVID-19.分析 COVID-19 期间知识问答社区中用户情绪和意见领袖信息传播行为的演变。
Int J Environ Res Public Health. 2021 Nov 22;18(22):12252. doi: 10.3390/ijerph182212252.
5
COVID-19-related skin manifestations: Update on therapy.COVID-19 相关皮肤表现：治疗进展。
Clin Dermatol. 2021 Sep-Oct;39(5):920-926. doi: 10.1016/j.clindermatol.2020.12.003. Epub 2020 Dec 14.
6
COVID-19 and Dermatology: One Year in Review.新型冠状病毒肺炎与皮肤病学：回顾一年
Dermatol Clin. 2021 Oct;39(4):xv-xvi. doi: 10.1016/j.det.2021.06.001. Epub 2021 Jun 14.
7
How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries.《2019 年冠状病毒病在全球范围内一年内如何改变皮肤科实践：来自 11 个国家的观点》。
Dermatol Clin. 2021 Oct;39(4):639-651. doi: 10.1016/j.det.2021.05.014. Epub 2021 May 31.
8
The Multifaceted Engagement of the Dermatologist in the Covid-19 Pandemic.皮肤科医生在新冠疫情中的多方面参与
SN Compr Clin Med. 2020;2(9):1388-1392. doi: 10.1007/s42399-020-00423-9. Epub 2020 Jul 22.
9
Safety guidelines for nonsurgical facial procedures during COVID-19 outbreak.COVID-19 疫情期间非手术面部治疗的安全指南。
J Cosmet Dermatol. 2020 Aug;19(8):1829-1837. doi: 10.1111/jocd.13530. Epub 2020 Jul 1.
10
COVID-19 Pandemic: Consensus guidelines for preferred practices in an aesthetic clinic.COVID-19 大流行：美容诊所首选实践的共识指南。
Dermatol Ther. 2020 Jul;33(4):e13597. doi: 10.1111/dth.13597. Epub 2020 Jun 13.
本文引用的文献
1
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
2
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
3
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
4
Modernizing clinical practice guidelines for the American Academy of Dermatology.美国皮肤病学会临床实践指南的现代化。
J Am Acad Dermatol. 2020 Jun;82(6):1487-1489. doi: 10.1016/j.jaad.2019.12.075. Epub 2020 Jan 21.
Zotero 插件